Pioneer transcription factors, including FOXA1, HOXB13, and GATA2, as well as the transcription factor ERG, have prominent roles to play in earlier, hormone-sensitive stages of the disease and in CRPC where AR signaling remains a mainstay of prostate tumor growth. Here, GATA2 is linked to prostate neoplasm.